We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Contracts for Difference terms and conditions.
How to use an N-of-1 study to evaluate your digital health product.
How to use a case-control study to evaluate your digital health product.
How to tax a beneficial loan arrangement for a director or employee.
How to use a before-and-after study to evaluate your digital health product.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
Explains how conditions attached to a planning permission should be used and discharged effectively
Find out about the CDC2 programme and when preliminary meetings and school site visits will take place.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).